Company: TELO
Filing Date: 2025-02-04
Form Type: 10-K
Source: 0001493152-25-004872
Chunk: 494

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-02-04
Form: 10-K
Item: Item 1A
Chunk 494
---
 copy of which is filed as an exhibit to this Report and is incorporated herein by reference.

69

Item
12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

The
following table sets forth, as of the date of this Report, the ownership of our securities by: (i) each of our directors, (ii) all persons
who, to our knowledge, are the beneficial owners of more than 5% of the outstanding shares of common stock, (iii) each of the executive
officers, and (iv) all of our directors and executive officers, as a group. Each person named in this table has sole investment power
and sole voting power with respect to the shares of common stock set forth opposite such person’s name, except as otherwise indicated.

    Name of beneficial
    owner 
    Amount
    and Nature of Beneficial Ownership  
    Percentage
    of Class as of February 4, 2025 
  
    Directors and Executive
    Officers 

    Erez Aminov 
     1,009,685  
     3.28%
  
    Michelle Yanez 
     24,391  
     * 
  
    Matthew Whalen 
     12,500  
     * 
  
    Matthew Del Giudice 
     12,500  
     * 
  
    Edward MacPherson 
     12,500  
     * 
  
    Craig Eagle 
     487,805  
     1.64%

    All current directors and
    officers as a group (6 persons) 
     1,559,381  
     5.13%

    5% Stockholders 

    Brian McNulty(1) 
     10,949,152  
     34.11%

    *Represents beneficial ownership of less than
    1% 

    (1)
    Includes
    (i) 5,406,431 shares held by the Bay Shore Trust, (ii) 1,853,659 shares held by the Celeste J. Williams Lifetime QTIP Trust, (iii)
    24,391 shares held directly by Mr. McNulty, (iv) 1,325,646 shared held by Miralogx LLC in which Bay Shore Trust is the beneficial
    owner and (v) 2,339,025 shares issuable pursuant to a warrant held by the Bay Shore